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Abstract 
Generalized anxiety disorder (GAD) is highly prevalent and incapacitating. Here we 
used the Carioca High-Conditioned Freezing (CHF) rats, a previously validated 
behaviorally selected animal model for GAD, to identify biomarkers and structural 
changes in the hippocampus that could be part of the underlying mechanisms of their 
high-anxiety profile. Spatial and fear memory was assessed in the Morris water maze 
and passive avoidance test. Serum corticosterone levels, immunofluorescence for 
glucocorticoid receptors (GR) in the dentate gyrus (DG), and western blotting for 
hippocampal brain derived neurotrophic factor (BDNF) were performed. 
Immunohistochemistry for markers of cell proliferation (bromodeoxiuridine/Ki-67), 
neuroblasts (doublecortin), and cell survival were undertaken in the DG, along with 
spine staining (Golgi) and dendritic arborization tracing. Hippocampal GABA release 
was assessed by neurochemical assay. 
Fear memory was higher among CHF rats whilst spatial learning was preserved. Serum 
corticosterone levels were increased, with decreased GR expression. No differences 
were observed in hippocampal cell proliferation/survival, but the number of newborn 
neurons was decreased, along with their number and length of tertiary dendrites. 
Increased expression of proBDNF and dendritic spines was observed; lower ratio of 
GABA release in the hippocampus was also verified. These findings suggest that 
generalized anxiety/fear could be associated with different hippocampal biomarkers, 
such as increased spine density, possibly as a compensatory mechanism for the 
decreased hippocampal number of neuroblasts and dendritic arborization triggered by 
high corticosterone. Disruption of GABAergic signaling and BDNF impairment are also 
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proposed as part of the hippocampal mechanisms possibly underlying the anxious 
phenotype of this model. 
Keywords: fear memory; anxiety; adult hippocampal neurogenesis; BDNF; dendritic 
arborization; dendritic spines. 
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1. Introduction 
 Anxiety disorders, such as generalized anxiety disorder (GAD), are among the 
most prevalent psychiatric conditions [1]. GAD is characterized by generalized, chronic 
and excessive worry and anxiety, accompanied by disruptive somatic symptoms and 
cardiovascular changes [2]. It has been associated with significantly reduced quality of 
life [3], and it is estimated to be as incapacitating as depressive disorders [4]. Effective 
interventions require the investigation of the underlying structural and functional 
psychobiology of this condition, with appropriate animal models being a key tool for 
this. 
 As proposed for psychiatric disorders in general, GAD is a multifactorial 
condition, with disruptive functioning of different brain areas – such as the prefrontal 
and cingulate cortex, as well as the amygdala [5] - possibly participating together in its 
etiology and development. Furthermore, hippocampal abnormalities in GAD patients 
have also been proposed [6]. In rodents, some of the neurobiological aspects 
demonstrated to be involved in anxiety also include those related to hippocampal 
function and plasticity, such as components of the GABAergic and glutamatergic 
systems [7], the expression of brain-derived neurotrophic factor (BDNF) [8], 
spinogenesis [9], as well as adult hippocampal neurogenesis (AHN) [10]. In addition, 
anxiety has been linked with elevated glucocorticoid levels [11], which have also been 
associated with reduced dendritic arborization in the hippocampus [12]. 
 The hippocampus is a crucial structure for contextual fear learning, which is in 
turn considered an appropriate paradigm for establishing animal models of GAD [2, 13, 
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14]. The present work investigated biomarkers of hippocampal plasticity in the Carioca 
High-Conditioned Freezing rats (CHF), an established and validated animal model of 
generalized anxiety. The CHF rodent population is an experimental group behaviorally 
selected for high freezing response in contextual fear conditioning [15]. A previous 
work established the CHF as a behaviorally validated model for the study of 
spontaneous high-anxiety [16], as differences were found only in anxiety-related 
paradigms and not in the forced swimming test of depression or the object recognition 
test, used as a paradigm for measuring cognitive skills. However, spatial and fear 
memory had yet to be investigated in this model. For these purposes, in the present 
work animals were exposed to the Morris water maze (MWM) and passive avoidance 
test (PAT). Importantly, the neural aspects underlying their anxious phenotype 
remained unclear. To investigate some of the possible hippocampal-related aspects 
underlying this model, 5-bromodeoxiuridine (BrdU) and Ki-67 were utilized as markers 
of proliferating cells in the dentate gyrus (DG), and immunohistochemical analysis of 
doublecortin (DCX) was performed to label neuroblasts [17] and to characterize 
dendritic arborization of these newly born neurons. BrdU positive cells in hippocampal 
sections of animals sacrificed 5 weeks after the last injection of this marker were taken 
as a measure of newborn cell survival. 
As corticosterone levels are believed to modulate hippocampal function, serum 
corticosterone and expression of glucocorticoid receptors (GR) in the DG were 
determined. In addition, levels of hippocampal precursor proBDNF  were identified and 
expression of dendritic spines was evaluated, as well as GABA release.  
We propose that generalized anxiety can result in part from multiple structural 
and biochemical plastic mechanisms in the hippocampus possibly orchestrated to 
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protect the individual from chronic exposure to high corticosterone levels, but leading to 
facilitation of fear memory retention.  
 
2. Materials and Methods 
2.1. Animals 
 Experimental procedures followed the Brazilian Society of Neuroscience and 
Behavior (SBNeC) guidelines, in accordance with the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals (NIH Publications). Handling and 
methods of sacrifice were approved by the Committee for Animal Care and Use of the 
CCS/UFRJ (protocol # IBCCF002). Experimental animals (Carioca High-Freezing 
[CHF], a line of Wistar rats selectively bred for their high conditioned freezing response 
in contextual fear learning) were obtained as described previously [15]. Briefly, albino 
Wistar rats were exposed to the contextual fear conditioning paradigm, and selectively 
bred for differences in defensive freezing behaviour in response to the conditioned 
context. Significant differences in freezing response were acquired after three 
generations of selective breeding (S3). In order to preserve the spontaneous differences 
between the experimental and the control groups, the animals used herein were not 
exposed to contextual fear conditioning or any aversive stimuli prior to 
experimentation. However, other individuals from all breeding generations were tested 
in the contextual fear conditioning paradigm for confirmation of the fear trait across 
generations. Breeding generations S9, S13 and S14 were used in the present study (Fig. 
1). 
--------------------------------------------------------------- 
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INSERT FIGURE 1 HERE 
---------------------------------------------------------------- 
 
 The control group (CT) was composed of the offspring of randomized cross-
breeding populations, thus encompassing animals with high, low and average 
conditioned freezing responses. Two- to three-month-old males were used, kept in 
acrylic cages (31 cm x 38 cm) in groups of 6 under a 12 h light/dark cycle, with food 
and water ad libitum. The animals’ dark/light cycle was inverted one week prior to 
behavioral testing, and procedures occurred during their dark cycle. Animals were used 
once in each experiment, except for those exposed to the MWM, which underwent the 
PAT 3 days after the MWM probe trial. Since both groups were exposed simultaneously 
to the same environmental conditions and experimental design, it is expected that 
baseline differences between the two groups are preserved.  
2.2. Behavioral Analysis 
2.2.1. Morris water maze 
 A polyethylene tank (1200 mm diameter x 500 mm height) and crystal acrylic 
platform (130 mm diameter x 300 mm height) were used. Experimental procedures 
followed those described elsewhere [18]. To verify locomotor activity, animals (n = 12 
CHF/ 12 CT) were individually placed in the tank with transparent water and allowed to 
swim for 2 minutes or until they reached the platform. Five trials were performed, each 
with the platform placed in different locations; latency was registered. On days 2 - 6, 
animals performed 5 trials, each with different starting points. During these, water in the 
tank received non-toxic white paint treatment, and the platform was placed 2 cm below 
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water level. On day 7, the platform was removed and the probe trial was performed. 
Animals’ performance was recorded and later analyzed by AnyMaze software (version 
4.84).  
2.2.2. Passive avoidance test 
 The apparatus consisted of an aluminum arena containing a safe platform (200 
mm x 75 mm) and a grid area (200 mm x 225 mm) where electrical stimulation could be 
administered. On day 1, each animal (n = 19 CHF/ 18 CT) was placed in the platform 
and a 0.5 mA footshock was administered for 1s every time it stepped down. The 
amount of footshocks received until the animal remained in the platform for 2 
uninterrupted minutes was registered (acquisition index). On day 2, each animal was 
placed again on the platform and the latency to step down was registered (retention 
index). Maximum time established = 120 s. 
2.3. Neurobiological Analysis 
2.3.1. BrdU administration 
 Animals received three intraperitoneal injections of BrdU (100 mg/kg) 
administered at 10 mg/ml, approximately every 16 h. Animals were perfused 24 h (n = 
08 CHF/ 05 CT) or 5 weeks (n = 03 CHF/ 03 CT) after the last injection. 
2.3.2. Euthanasia and brain sectioning 
 Animals used for immunohistochemistry were anesthetized and perfused 
through the left ventricle of the heart with saline and 4 % paraformaldehyde in 0.1 M 
phosphate buffer. Brains were removed and cryoprotected in 30 % sucrose for 1 week. 
Serial 40 µm coronal brain sections were obtained on a cryostat and stored in TBS-AF 
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(tris buffered saline + anti-freezing solution of 0.05 % sodium azide, 30 % glycerol and 
15 % sucrose) at 4 °C. 
2.3.3. BrdU immunohistochemistry 
 Sections were washed (n = 08 CHF/ 05 CT for analysis of cell proliferation; n = 
03 CHF/ 03 CT for analysis of cell survival), exposed to 1 % hydrogen peroxide for 30 
minutes, washed again and kept for 30 minutes at 37 °C in 2 N HCl, following 2 x 10-
minute immersions in 0.1 M borate buffer at room temperature. Sections were washed 
and exposed to 3 % normal horse serum (NHS) (Vector Laboratories, S-2000) for 2 h. 
Sections were incubated overnight with anti-BrdU primary antibody (Serotec 
MCA2060B; 1:500 in 3 % NHS), washed, and incubated with goat anti-rat secondary 
antibody (Vector Laboratories, BA-9400; 1:250 in 3 % NHS) for 2 h. Sections were 
washed, and incubated in ABC complex (Vector Laboratories, PK-6100, Vectastain® 
Elite ABC-Peroxidase Kits; 1:1,000) for 2 h. Following washes, the reaction was 
revealed by diaminobenzidine (DAB) (Sigma, D5637-5G). Slides were mounted in 
Entellan (Merck, HX075822).  
 
2.3.4. Ki-67/ DCX immunohistochemistry 
 Sections were washed, exposed to 1 % hydrogen peroxide for 30 minutes, 
washed and kept for 2 h in 15 % NHS. Sections were incubated overnight with anti-Ki-
67 primary antibody (ABCAM, AB16667; 1:500 in 10 % NHS) (n = 08 CHF/ 08 CT) or 
anti-DCX primary antibody Santa Cruz, SC-8066; 1:200 in 10 % NHS) (08 CHF/ 08 
CT). Sections were washed, and incubated with horse anti-rabbit biotinylated secondary 
antibody (Vector Laboratories, BA-1100; 1:200 in 10 % NHS), in the case of Ki-67, or 
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with peroxidase horse anti-goat antibody (Vector Laboratories, PI-9500; 1:200), for 
DCX staining. Finally, Ki-67 sections were washed, and incubated in ABC 1:1000 for 2 
h. Revelation and mounting followed procedures described for BrdU immunostaining.  
2.3.5. Stereological analysis 
 Cells were counted by stereology [19], in a 1-in-6 series of sections (240µl 
apart), starting rostrally and progressing caudally, through a 40x objective. The DG was 
traced using a semiautomatic stereology system (StereoInvestigator, MicroBrightfield) 
and a 2.5x objective. For each section, the system was set to randomly place a 50 µm x 
50 µm counting frame throughout the traced DG. Only those stained cells that were 
either within the counting frame or touching the green border of the counting frame 
were counted. The total number of positive cells was estimated using the optical 
fractionator method, by relating the number of cells counted to the DG sectional 
volume. 
2.3.6. Corticosterone radioimmunoassay 
 Animals (n = 10 CHF/ 10 CT) were euthanized by decapitation, and blood was 
collected for hormone concentration analysis. Serum was obtained after centrifugation 
of the blood at 1,200 g for 20 minutes and stored at -20 °C. Serum corticosterone was 
determined using a specific coated tube RIA kit; intra- and inter-assay coefficients of 
variation were 4.0 - 12.2 % and 4.8 - 14.9 %, respectively, and sensitivity was 5.7 
ng/mL (Coat-a-Count Rat Corticosterone, Siemens Medical Solutions Diagnostics). 
Procedures followed the manufacturer’s recommendations. 
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2.3.7. GR immunofluorescence 
 Sections were washed and exposed to 5 % bovine serum albumin (BSA) for 1 h, 
following overnight incubation with anti-GR primary antibody (Santa Cruz GR (H-
300): sc-8992; 1:200) (n = 09 CHF/ 12 CT). Sections were then washed and incubated 
with anti-rabbit secondary antibody (Alexa 555; 1:500) in a dark chamber. Slides were 
mounted in N-propyl galate and imaged through a 40x objective with a fluorescent 
microscope (Zeiss Axioskop, Axiovision software). GR expression in the DG was 
analyzed with ImageJ software (http://rsbweb.nih.gov/ij/) and expressed as Corrected 
Total Cell Fluorescence (CTCF). 
2.3.8. Dendrite visualization and quantitative morphometric analysis 
 Granule neurons expressing DCX were imaged using a 40x objective, and 
micrographs were acquired using a Zeiss AxioCam MR Rev3 camera, following 
procedures previously described [20]. Dendrites were traced, categorized and analyzed 
using the NeuronJ plugin for ImageJ (http://rsbweb.nih.gov/ij/) by a blinded 
experimenter (8 neurons traced per animal; n = 08 CHF/ 08 CT). 
.   
2.3.9. Dendritic spine density 
 Animals (04 CHF/ 04 CT) were euthanized by decapitation, and brain 
hemispheres underwent Golgi impregnation method (Kit FD Rapid GolgiStainTM - 
PK401), following the manufacturer’s instructions. Sections were obtained in a cryostat 
(100 µm; -22 ºC). After staining completion, slides were mounted in Entellan, and kept 
protected from light. Tertiary dendritic shafts (8 per animal) were visualized using a 63x 
objective (Axiovert 35 microscope) and imaged by a Zeiss Axiocam MRm camera. 
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Individual spines were distinguished by contrast adjustment and quantified in ImageJ 
software. 
2.3.10. BDNF expression 
 Hippocampi of both groups (n = 04 CHF/ 04 CT) were dissected and transferred 
to lysis buffer. The tissue was sonicated (3 cycles of 10 s at 50 Hz) and protein 
concentration was determined [21]. Samples were diluted in lysis and sample buffer to a 
final concentration of 3µg protein/µl, and heated for 5 minutes at 100 °C. Samples were 
loaded on a 10 % polyacrylamide gel and later transferred to a PVDF membrane at 10 V 
for 40 minutes, using a semi-dry system (Bio-Rad 170-3940). Next, the membrane was 
washed, blocked for 2 h with 2 % BSA, and incubated overnight with anti-BDNF 
primary antibody (Santa Cruz (N-20): sc-546, 1:1,000). After washing, it was incubated 
for 2 h with anti-rabbit HRP-conjugated secondary antibody (Sigma, A0545, 1:10,000). 
For the loading control, the membrane was stripped with glycine buffer for 30 minutes 
at room temperature, blocked with 5 % milk for 30 minutes, washed and incubated with 
anti-α-tubulin primary antibody for 30 minutes (Sigma, T5168, 1:50,000). Next, it was 
washed and incubated for 30 minutes with anti-mouse HRP-conjugated secondary 
antibody (Sigma, A5278, 1:5,000). All reactions were detected by chemiluminescence 
(Millipore, Luminata® system). 
2.3.11. GABA release 
 Hippocampi of both groups (n = 05 CHF/ 06 CT) were dissected and sectioned 
(400 µm). Loading was made with reaction solution (GABA 100 µM + 3H-GABA 0.25 
µCi). Slices were washed 3 x with Hank`s at 37 °C. The supernatant was collected in 6 
series, with 5 - minute intervals. Two Hank’s washing series were collected, as well as 
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two with high potassium Hank’s, and the last two with Hank’s. Total GABA is 
represented by lysate GABA + released GABA. Radioactivity was quantified by liquid 
scintillation counting. 
2.4. Preparation of figures 
 Digital images were created by using GIMP 2.8.6 (GNU Image Manipulation 
Program; www.gimp.org) and assembled into final figures. General adjustments of 
contrast and brightness were made where appropriate. 
2.5. Statistics 
 Data were analyzed in GraphPad Prism 5 using Student’s t-test for unpaired 
samples (expressed as mean ± S.E.M), one- and two-way analysis of variance 
(ANOVA) with post-hoc Bonferroni test. Differences were considered significant when 
p ≤ 0.05. 
 
3. Results 
3.1. Spatial learning is preserved in CHF rats 
 A reliable model of anxiety should only feature aspects directly related to the 
phenotype it intends to reproduce. Therefore, to strengthen the characterization of the 
CHF as a strict model for anxiety without signs of cognitive degeneration/impairment, 
animals were tested in the MWM. With regard to the latency to reach the invisible 
platform, there was a significant effect of day (F (4,352) = 11.3739; p < 0.0001), but no 
effect of groups (F (1,13) = 0.1039; p = 0.752) or of the interaction (F (4,352) = 0.8974; 
p = 0.466) (Fig. 2A), showing that both groups similarly improved their performance 
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along the test days and trials. Accordingly, there was a significant effect of total 
distance travelled with regard to day (F (4,568) = 26.6464; p < 0.0001), but not to 
groups (F (1,22) = 3.1891; p = 0.088) or to the interaction (F (4,568) = 0.7712; p = 
0.544) (Fig. 2B), suggesting that both CT and CHF rats present decreased distance 
travelled along trials (Fig. 2C), and thus are not impaired in this spatial learning task.  
--------------------------------------------------------------- 
INSERT FIGURE 2 HERE 
---------------------------------------------------------------- 
 No differences were observed between CT and CHF rats with regard to the 
number of entries in the target zone in the probe trial (7.833 ± 0.4578 CT, n = 12; 10.17 
± 1.296 CHF, n = 12; p = 0.1037) (Fig. 3A), demonstrating that spatial memory is 
preserved in the anxious group, despite their chronic stress phenotype. Interestingly, the 
latency to enter the target zone was significantly decreased among CHF animals (3.858 
± 0.7718 s CT, n = 12; 1.900 ± 0.2923 CHF, n = 12; p = 0.0268) (Fig. 3B). They also 
spent less time in this quadrant (23.45 ± 1.307 CT, n = 12; 17.84 ± 1.373 CHF, n = 12; 
p = 0.0073) (Fig. 3C), showing more exploration of other locations of the tank when 
facing the absence of the safe platform. No differences were observed in the visible 
platform trials (Supplementary data S1). 
--------------------------------------------------------------- 
INSERT FIGURE 3 HERE 
---------------------------------------------------------------- 
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3.2. CHF rats display enhanced fear memory 
 The enhanced ability to recall aversive information in emotional contexts is a 
phenomenon observed among anxious patients [22, 23]. To test the hypothesis of 
enhanced ability to form and/or store aversive memories among CHF animals, the PAT 
was used. No difference was observed in the number of shocks administered on day 1 
(2.611 ± 0.2003 CT, n = 18; 2.211 ± 0.1636 CHF, n = 19; p = 0.1287) (Fig. 4A), 
showing similar capacity for aversive learning in both groups. However, CHF animals 
presented a significantly increased latency to step down from the platform (64.94 ± 
12.57 s CT, n = 18; 107.7 ± 7.096 s CHF, n = 19; p = 0.0049) (Fig. 4B), demonstrating 
enhanced rate of fear memory retention. 
--------------------------------------------------------------- 
INSERT FIGURE 4 HERE 
---------------------------------------------------------------- 
3.3. Basal serum corticosterone levels are increased in CHF animals 
 Although corticosteroids do not directly regulate emotional behavior, they are 
believed to weaken or strengthen certain neural pathways, leading to altered behavioral 
outcomes [24] [25]. As shown in Fig. 5A, basal corticosterone levels were significantly 
higher in CHF animals (118.9 ± 27.97 CT; 339.0 ± 49.38 ng / mL CHF; n = 10; p = 
0.0011), consistent with the anxious behavioral profile displayed by the experimental 
group.   
--------------------------------------------------------------- 
INSERT FIGURE 5 HERE 
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---------------------------------------------------------------- 
3.4. CHF rats have decreased expression of GR in the DG 
 Considering that, at high circulating levels, corticosteroids enhance the 
acquisition, conditioning and consolidation of stressful experiences via GR [26], 
analysis of this receptor expression was performed. A significant decrease was verified 
in the DG of CHF animals (CTCF, 3,604 ± 298.3 CT, n = 12; 2,385 ± 266.5 CHF, n = 9; 
p = 0.0085) (Fig. 5B), probably resulting from a negative feedback loop from the 
increased corticosterone levels. 
3.5. Hippocampal cell proliferation and survival are not altered in CHF rats 
 A reduction in AHN has also been proposed to underlie dysfunctionality in 
anxiety disorders [27]. As a first step to investigate this aspect in CHF rats, 
quantification of cell proliferation markers in the DG was performed. As shown in Fig. 
6A, no differences were found in the total estimated number of BrdU+ (cells / mm3: 
3,061 ± 483.0 CT, n = 5; 3,545 ± 396.3 CHF, n = 8; p = 0.4592) or Ki-67+ cells (cells / 
mm3: 2,097 ± 214.7 CT, n = 8; 2,563 ± 291.1 CHF, n = 8; p = 0.2184). In addition, 
quantification of BrdU+ cells in animals sacrificed 5 weeks after the last injection 
revealed no differences in cell survival between groups (cells / mm3: 2,721 ± 542.6 CT, 
n = 3; 2,519 ± 341.2 CHF, n = 3; p = 0.7693) (Fig. 6B). This shows that the behavioural 
profile observed in the CHF group may be due to other mechanisms rather than cell 
proliferation and survival in the DG. 
--------------------------------------------------------------- 
INSERT FIGURE 6 HERE 
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3.6. Hippocampal number of neuroblasts is decreased in CHF rats 
 Analysis of DCX, a microtubule-associated protein expressed exclusively in 
immature neurons, was performed to verify differences in newborn neurons. Indeed, 
DCX quantification revealed a decrease in the number of neuroblasts in the DG of CHF 
rats (cells / mm3: 16,310 ± 1630 CT, n = 8; 11,870 ± 1115 CHF, n = 8; p = 0.0411) (Fig. 
7), suggesting a possible decrease in AHN in the CHF group.  
--------------------------------------------------------------- 
INSERT FIGURE 7 HERE 
---------------------------------------------------------------- 
3.7. Neuroblasts in CHF rats display altered dendritic morphology 
 Given that the dendritic field largely defines the synaptic input of the cell [20], 
and thus, its functionality, the dendritic architecture of these young neurons was 
analyzed. As shown in figure 8, the analysis of dendrite number and length revealed 
alterations in the dendritic morphometry of newly born neurons of CHF animals, 
especially in total dendrite number (6.938 ± 0.3164 CT, n = 64; 5.719 ± 0.2611 CHF, n 
= 64; p = 0.0036, fig. 8A) and length of dendrites (µm: 336.9 ± 17.21 CT, n = 64; 289.2 
± 13.75 CHF, n = 64; p = 0.0324, fig. 8B). Further investigation revealed that decreased 
dendritic arborization was due to reduced tertiary dendrite number (3.906 ± 0.3147 CT, 
n = 64; 2.703 ± 0.2604 CHF, n = 64; p = 0.0038, fig. 8A) and length (µm: 183.1 ± 16.90 
CT, n = 64; 138.3 ± 14.77 CHF, n = 64; p = 0.0482, fig. 8B). This parallels with studies 
showing an association between stress and modifications in dendritic architecture, 
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especially dendritic retraction in the hippocampus [12, 28-31], and may suggest a 
protective response to reduce the contact surface of the neuron with the neurochemical 
environment altered by the chronic stress condition these animals present.  
 No differences were seen in the length of primary dendrites (µm: 40.96 ± 3.598 
CT, n = 64; 38.14 ± 3.393 CHF, n = 64; p = 0.5691, fig. 8a) or in the number (2.031 ± 
0.02192 CT, n = 64; 2.016 ± 0.01563 CHF, n = 64; p = 0.5627, fig. 8a) or length (µm: 
112.5 ± 7.136 CT, n = 64; 112.1 ± 6.952 CHF, n = 64; p = 0.9706, fig. 8b) of secondary 
dendrites.  
--------------------------------------------------------------- 
INSERT FIGURE 8 HERE 
---------------------------------------------------------------- 
3.8. CHF animals have more dendritic spines in the DG 
 Dendritic arborization, however, is not the only important morphological 
indicator of the ability of a neuron to receive synaptic inputs. Another important aspect 
is the expression of dendritic spines, micro-specializations of the dendritic shafts to 
establish functional contacts with other cells. Alterations in spine density are associated 
with changes in synaptic strength [32], especially in the context of excitatory synapses 
[33], which are crucial for memory formation [34-36]. In contrast to what was observed 
for dendritic architecture of neuroblasts, quantitative analysis of dendritic spines in 
tertiary branches of DG neurons revealed that CHF rats displayed higher dendritic spine 
linear density compared to the CT group (spines / 10 µm: 14.64 ± 0.4105 CT, n = 32; 
17.10 ± 0.5231 CHF, n = 32; p = 0.0005) (Fig. 9), supporting the hypothesis that the 
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anxious group displays enhanced hippocampal machinery for certain plasticity-related 
functions. 
--------------------------------------------------------------- 
INSERT FIGURE 9 HERE 
---------------------------------------------------------------- 
3.9. Expression of hippocampal proBDNF in the CHF group is increased 
 Other parameters of hippocampal plasticity were also investigated, in the search 
for neural aspects that could, at least partly, explain the enhanced fear memory and 
anxiety traits displayed by the CHF model. One of these parameters was hippocampal 
BDNF expression, known to underlie newborn cell survival, synaptic formation and 
plasticity [37]. A significant increase in hippocampal expression of proBDNF (32kDa) 
was observed in CHF animals (0.1731 ± 0.05977 CT, n = 4; 1.107 ± 0.1659 CHF, n = 4; 
p = 0.0018) (Fig. 10), a feature that could contribute to the preserved cell survival rates 
found and for the enhanced retention of fear memory if it also reflects increased 
cleavage into mature BDNF. 
--------------------------------------------------------------- 
INSERT FIGURE 10 HERE 
---------------------------------------------------------------- 
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3.10. The hippocampus of CHF animals release less GABA under stimulation with 
K+ 
 Since the GABAergic system exerts a classic inhibitory effect, with its receptors 
being the target of widely used anxiolytic drugs [38], it was considered important to 
investigate some functional aspect of this system in the CHF model. For this, a 
neurochemical assay of GABA release was performed. Results showed that, under 
stimulation with K+, CHF hippocampal samples released less GABA than those from 
CT (2.953 ± 0.3489 CT, n = 6; 1.668 ± 0.2151 CHF, n = 5; p=0.0155) (Fig. 11). This is 
strong evidence for a decreased inhibitory activity in the hippocampus of the CHF 
group, which may be part of the mechanism underlying the highly anxious behavioural 
profile previously reported [16]. 
--------------------------------------------------------------- 
INSERT FIGURE 11 HERE 
---------------------------------------------------------------- 
 
4. Discussion  
Although GAD is highly prevalent and incapacitating, the neural correlates 
underlying its symptoms remain unclear. Previously, the behavioral aspects of CHF rats, 
an experimental model for GAD, have been investigated [16]. This group spontaneously 
displays an anxious phenotype in the elevated plus-maze and social interaction tests, 
with no differences in the forced swimming test of depression, or in the declarative 
memory assessed by the object recognition test. Additionally, no differences in the total 
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number of cells in the dorsal hippocampus were found. However, the involvement of 
the hippocampus in risk assessment, the cognitive component of fear memory, and in 
contextual fear conditioning [39] indicated the need for additional investigations of this 
brain structure in the CHF. Moreover, further assessment of cognitive and fear memory 
was considered crucial for strengthening the characterization of the model. 
Confirming previous data on locomotor activity, visual perception and cognitive 
learning [16], the MWM showed similar performance of CHF and CT rats in all days of 
visible platform testing (Supplementary data S1). Interestingly, in the probe trial, CHF 
animals presented decreased latency to enter the target zone, which could indicate 
enhanced ability to retain information on the environment, especially in aversive 
conditions lacking escape alternatives. Also, CHF animals spent less time in the target 
quadrant, a parameter that could indicate enhanced perception of the environment as 
threatening or even some difficulty to adapt to it, since after all trials, some 
environmental habituation would be expected. This hypothesis of increased memory in 
emotional contexts was explored in the PAT, where CHF rats presented enhanced 
retention index. Taken together, both the MWM and PAT confirmed that the learning 
ability of CHF animals is preserved, but memory retention in emotional contexts is 
enhanced. Interestingly, the tendency to associate stimuli in stressful conditions is a 
feature consistently observed in anxious patients [22, 23]. 
Components of the hypothalamic-pituitary-adrenal axis (HPA) are among the 
most important biomarkers of stress in rodents [40], and particularly in anxious rat lines 
[41]. For instance, high-anxious rats from a line selected in the elevated plus-maze 
exhibited increased secretion of adrenocorticotropic hormone and corticosterone [42, 
43]. The higher HPA response in conditioned, fear-selected rats [42] suggests that 
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hyperanxious animals may over-interpret certain stimuli, a behavior that also occurs in 
psychiatric patients. Corticosterone, likely acting via GR in the hippocampus, also plays 
a facilitatory role in acute freezing behavior [26], which is one of the behavioral 
characteristics of the CHF line [15]. Here, we report that CHF rats exhibit significantly 
higher levels of corticosterone, a feature that correlates with the decreased expression of 
GR in their DG. 
Besides alterations in the HPA axis, reduced hippocampal volume has been 
observed in anxiety and mood disorders [44]. However, this aspect was found to be 
unaltered in CHF animals (Supplementary data S2), despite the reduced hippocampal 
dendritic arborization of neuroblasts observed. It is possible that the maintenance of cell 
proliferation and survival could have contributed to the preservation of hippocampal 
volume. This hypothesis is supported by previous data showing that over-expression of 
BDNF in the amygdala and hippocampus correlates with high anxiety and unaltered 
volume [8]. Additionally, we previously reported that the total number of hippocampal 
cells was similar between CHF and CT [16], pointing to more molecular, rather than 
macro-structural, alterations in this model. Accordingly, we investigated cellular 
markers in the context of AHN, and showed that cell proliferation and survival are not 
altered among CHF animals. This could, at least in part, explain the non-depressive 
profile of these animals [16], since differences in BrdU labelling have been consistently 
correlated with depression models [45, 46]. 
On the other hand, the number of neuroblasts was found to be decreased in CHF 
rats. Interestingly, a reduced number of newly born hippocampal neurons in aged rats 
was shown to be sufficient for fear learning [47], which might also be applicable in our 
model. In fact, it can be hypothesized that a reduced number of neurons is not only 
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sufficient for fear conditioning in the CHF rats but is one of the neural features that 
could be responsible for their strong fear memory retention and behaviorally anxious 
phenotype. It has been shown that early life stress can lead to altered dendritic 
morphology and enhanced contextual fear learning in maternally deprived animals [48]. 
Additionally, under high levels of corticosterone, even long-term potentiation (LTP) in 
the DG of these stressed animals was facilitated. Considering these, alterations in 
neurogenesis, synaptogenesis, neurotransmission and/or the neuroendocrine system 
could modulate and enhance fear memory, leading animals to exhibit increased fear 
responses. Strong evidence for this comes from the findings of dendritic spine 
expression and decreased GABAergic inhibition in the hippocampus. Opposite roles for 
pro- and mature BDNF have been proposed [49], with the former being associated with 
long-term depression and apoptosis [32], and the latter with enhanced cell survival and 
plasticity [50]. If the increased expression of proBDNF observed in the CHF 
hippocampus reflects increased availability for cleavage into mature BDNF, it could 
also contribute for the hypothesis that the over-expression of certain biomarkers of 
hippocampal plasticity could result in enhanced fear memory retention and anxiety. 
Although further studies are needed to confirm the involvement of each of these aspects 
with fear and anxiety in the CHF rats, other features, including LTP and the 
involvement of brain regions like the amygdala and medial pre-frontal cortex, might be 
present and could interact, resulting in the spontaneously anxious phenotype observed in 
this rat line. Increased gliogenesis and/ or faster maturation of granule neurons could 
also take place in the DG of the CHF group, given the findings of decreased number of 
neuroblasts with unaltered rates of cell proliferation and survival showed herein. In this 
sense, further assessment of neurogenesis/ gliogenesis by double-labeling of 
BrdU+NeuN (NeuN – neuronal nuclei, marker of mature neurons) and BrdU+GFAP 
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(GFAP - glial fibrillary acidic protein, marker of astrocytes) is still needed to confirm 
this hypothesis and contribute for the understanding of the anxious phenotype observed 
in the CHF model. 
An association between anxiety and decreased cell proliferation/ survival, and 
spinogenesis has been consistently proposed [51]. However, this overall reduction of 
structural plasticity appears not to fully link with the increased fear learning observed in 
clinical and experimental anxiety. Here, we show that increased anxiety does not always 
correlate with reduced cell proliferation/survival and spine expression. Furthermore, we 
propose that given that natural compensatory mechanisms must take place in the brain 
to prevent the deleterious effects of glucocorticoids [52], dendritic arborization could be 
seen as a buffering process by the hippocampal system to avoid cell loss [44]. 
Consistent with previous data on stress and fear [53], decreased dendritic arborization in 
the CHF rats was associated with an increase in spine density . Along with other 
mechanisms such as decreased GABAergic inhibition, this increase in spinogenesis 
could, in turn, facilitate fear memory retention and anxiety. Thus, the findings presented 
here challenge our current view of decreased cell proliferation/survival and spinogenesis 
as biomarkers underlying all kinds of fear/anxiety-related conditions. In turn, it is 
proposed that the variability and complexity of anxious/fear traits must be addressed by 
the view that a differential expression of biomarkers must accompany the particular 
features of each set of behaviors modeled by a given paradigm.  
Although much remains to be unraveled, the findings reported here represent 
consistent indices for some novel neurobiological understanding of generalized anxiety 
in the context of hippocampal plasticity. Moreover, the particular features found may 
contribute to the important concept that a more complete view of symptoms observed in 
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clinical practice must come from different paradigms, each modeling specific anxiety-
related behaviors through specific neural substrates.  
5. Conclusion 
The data presented herein reinforces the CHF group as a consistent model for the 
study of anxiety and fear, since these are the only behavioral aspects found to be 
differentially expressed by the experimental group. In addition, some candidates to 
compose part of the neurobiological basis underlying the vulnerability of this group to 
higher levels of anxiety were identified. Among these, it can be highlighted the 
increased levels of corticosterone, accompanied by decreased expression of GR in the 
DG, reduced number and arborization of hippocampal neuroblasts, as well as disrupted 
inhibitory signaling in the hippocampus. Unexpectedly, cell proliferation and survival in 
the DG were unaltered and spine density in the DG was found to be increased. 
Additional assays aiming to identify the levels of mature BDNF and the role of 
proBDNF within the context of anxiety are needed. Together, these data suggest that 
some biomarkers – such as decreased spines - usually found in stress models cannot 
always apply to anxiety. Future studies are needed to further explore and confirm the 
specific neurobiological features - in the hippocampus and in other brain structures - 
that confer the fear trait of this model, so that it can be used as a tool for the screening 
of novel translational interventions for generalized anxiety.  
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Figure Captions 
Fig. 1. Experimental design. In a previous work, albino Wistar rats have been selected for their 
high-conditioned freezing response in the contextual fear paradigm; after three breeding 
generations (S3), significant differences were observed between high- and low- freezing 
animals, and the experimental group used herein was named the Carioca High-Conditioned 
Freezing rats [15]. In the present work, breeding generations S9, S13 and S14 were used. 
Animals that were exposed to the contextual fear conditioning paradigm for confirmation of the 
fear-trait phenotype in each given generation were not used in the experiments described here 
but their offspring. In this way, spontaneous differences between groups could be preserved 
and baseline behavioral and neurobiological differences could be identified, as opposed to 
differences due to the stress of undergoing the fear conditioning paradigm. 
Fig. 2. Spatial learning was assessed by the invisible platform test in the MWM. Latency to 
reach the platform in this spatial learning task of the MWM along the test days is shown in (A) 
and the total distance travelled in (B). There was no significant difference between groups in 
any trial, suggesting that spatial learning here is preserved in the anxious group (n = 12CT; 12 
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CHF). The pathway travelled by a CT and CHF animal in the beginning and end (after 72 
trials) of hidden platform testing in the MWM is plotted in (C). Note that the pathway travelled 
by both animals, representing their respective groups, decreases after trials. MWM Morris 
Water Maze, s seconds, m meters, CT control, CHF Carioca high-conditioned freezing 
Fig. 3. Spatial memory parameters were assessed in the probe trial of the MWM. Bar graphs 
show mean ± S.E.M number of entries in the target zone for CT (black) and CHF (grey) in (A). 
There was no difference between groups with regard to the number of entries in the target zone. 
Mean ± S.E.M latency to first entry in the target zone for CT (black) and CHF (grey) is shown 
in (B). CHF rats spent significantly less time to first entry into this quadrant, possibly 
indicating enhanced spatial memory in aversive conditions and/or less tolerance to being in an 
adverse environment. Time spent in the target zone for CT (black) and CHF (grey) is shown in 
(C), also as mean ± S.E.M. CHF rats spent significantly less time in the target zone, raising the 
hypothesis that these anxious animals present enhanced perception of the tank as an aversive 
context and/or display some difficulty to adapt to this kind of context (n = 12 CT; 12 CHF). 
Track plot of CT and CHF animal in the probe trial of the MWM is illustrated in (C). In the 
figure, the target zone corresponds to the left superior quadrant (zone SW). Although it is not 
possible to analyze in the figure all the parameters assessed in this trial, note the intensity of the 
plot of the CHF animal in quadrants that are not the target zone, indicating more time spent in 
other locations of the tank. SW southwestern quadrant, MWM Morris Water Maze, CT control, 
CHF Carioca high-conditioned freezing. *p ≤ 0.05, **p ≤ 0.01 
Fig. 4. Acquisition and retention of fear memory were analysed in the PAT. Bar graphs in (A) 
show the mean ± S.E.M number of shocks applied until the animal remained for 2 
uninterrupted minutes in the safe platform (measure of acquisition) for CT (black) and CHF 
(grey). CHF rats do not differ from CT in the fear learning parameter assessed in this test, as 
30 
 
can be observed by the similar amount of footshocks delivered in the first day of test. The 
latency to first step down from the safe platform (measure of retention) for CT (black) and CHF 
(grey) is shown in (B), as mean ± S.E.M. CHF animals display enhanced fear memory 
retention, as shown by the time spent in the safe platform before first step down in the second 
day of test (n = 18 CT; 19 CHF). PAT passive avoidance test, CT control, CHF Carioca high-
conditioned freezing. **p ≤ 0.01 
Fig. 5. Bar graphs in (A) show serum corticosterone levels (ng / ml) at basal condition for CT 
(black) and CHF (grey). There was a significant difference between CT and CHF groups, with 
the anxious animals presenting higher levels of the stress hormone. Values represent mean ± 
S.E.M (n= 10 CT; 10 CHF). Expression of GR measured by immunofluorescence for CT 
(black) and CHF (grey) was found to be significantly reduced in the dentate gyrus of the CHF 
group, as shown in (B) (n = 12 CT; 09 CHF). GR glucocorticoid receptor, CTCF Corrected 
Total Cell Fluorescence, CT control, CHF Carioca high-conditioned freezing. **p ≤ 0.01 
Fig. 6. Cell proliferation and survival in the dentate gyrus of adult CT and CHF animals were 
assessed by immunohistochemistry. Quantification of BrdU-positive cells in the dentate gyrus 
(DG)1 day after the last BrdU injection, and of Ki-67, are shown in (A) for CT (black) and 
CHF (grey). Stereological analysis revealed no differences between groups with regard to 
quantification of BrdU+ and Ki-67+ cells. (BrdU, n = 05 CT; 08 CHF; Ki-67, n = 08 CT; 08 
CHF). Stereological quantitative analysis of BrdU+ cells in the DG of animals sacrificed 5 
weeks after the last BrdU injection is shown in (B) for CT (black) and CHF (grey). This 
analysis revealed no differences between CT and CHF rats with regard to cell survival (n = 03 
CT; 03 CHF, values represent mean ± S.E.M). BrdU bromodeoxiuridine, CT control, CHF 
Carioca high-conditioned freezing, DG dentate gyrus 
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Fig. 7. Bar graphs show the mean ± S.E.M number of neuroblasts in the adult dentate gyrus 
(DG) of CT and CHF rats. Quantification of DCX+ cells in the DG of CT (black) and CHF 
(grey) is shown in (A). Stereological analysis showed a significant reduction of DCX+ cells in 
the DG of CHF animals (n = 08 CT; 08 CHF), suggesting decreased levels of neuronal 
differentiation in this group. Photomicrographs of the DG of both groups, stained for DCX are 
shown in (B). Note the reduction in DCX expression in the DG of CHF animal. Scale bars 
indicate 250 µm in (B) upper panels (4x objective) and 25 µm in (B) lower panels (40x 
objective). DCX doublecortin, CT control, CHF Carioca high-conditioned freezing, DG dentate 
gyrus. *p ≤ 0.05 
Fig. 8. Morphometric analysis of neuroblast dendrites was performed in order to evaluate 
dendritic arborization of immature neurons in the dentate gyrus (DG) of CT and CHF animals. 
Mean ± S.E.M number of total, secondary and tertiary dendrites in the newly born neurons in 
the DG of CT (black) and CHF (grey) is shown in (A). A significant difference was found in 
the total number of dendrites, reflecting a specific reduction in the number of tertiary dendrites 
in the CHF group (n = 64cells / group). Total, primary, secondary and tertiary length (µm) of 
dendrites of newly born neurons in the DG of CT (black) and CHF (grey) is shown in (B). CHF 
neuroblasts present decreased total dendritic length, as a reflection of the reduction observed in 
the length of tertiary dendrites (n = 64cells / group). In (C), the tracing of a neuroblast of CT 
and CHF animal illustrate the reduced number and length of dendrites in the experimental 
group. Scale bar indicates 40 µm. CT control, CHF Carioca high-conditioned freezing. *p ≤ 
0.05, **p ≤ 0.01 
Fig. 9. Bar graphs in (A) show dendritic spine linear density in tertiary dendrites of the dentate 
gyrus of CT and CHF animals, as mean ± S.E.M. Data show a significant increase in the 
expression of dendritic spines in the experimental group (n = 32 dendritic shafts / group). 
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Photomicrograph in (B), along with its high contrast representation used for spines 
quantification, shows the dendritic shafts from CT and CHF neurons; higher density of spines 
can be noted in the anxious group. Scale bar indicates 10 µm. CT control, CHF Carioca high-
conditioned freezing. ***p ≤ 0.001 
Fig. 10. Expression of BDNF in the hippocampus of CT and CHF animals was analysed by 
western blotting. A significant increase in the expression of this trophic factor in the 
experimental group was observed, as quantitatively shown in (A) (n = 04 CT (black bars); 04 
CHF (grey bars)). Quantification was made using ImageJ software and normalized to α-tubulin 
expression, as shown in (B). BDNF brain derived neurotrophic factor, CT control, CHF Carioca 
high-conditioned freezing. **p ≤ 0.01 
Fig. 11. Statistical analysis of [3H]-GABA release with depolarizing stimulus (KCl, 80 mM) by 
basal GABA release in 400 µm hippocampal slices of CT (black) and CHF animals (grey). The 
ratio of [3H]-GABA released is inferior in CHF slices (n = 06CT; 05 CHF), suggesting altered 
inhibitory response in the hippocampus of the anxious model. CT control, CHF Carioca high-
conditioned freezing. *p ≤ 0.05 
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